Calculation of population attributable risk for bidi smoking and oral cancer in south Asia

Clinical Practice Evaluation and Research Center, St. Luke's International Hospital & St. Luke's Life Science Institute, Akashi-cho 9-1, Chuo-ku, Tokyo 104-8560, Japan.
Preventive Medicine (Impact Factor: 3.09). 06/2005; 40(5):510-4. DOI: 10.1016/j.ypmed.2004.09.030
Source: PubMed


Bidi smoking, which is widely prevalent in India and in other south Asian countries, increases the risk of oral cancer as observed in case-control studies and metaanalysis. However, population attributable risk percent (PAR%) has not been determined yet.
Twelve case-control studies conducted in India, Pakistan, and Sri Lanka, which included information on bidi smoking and oral cancer, were analyzed countrywise to estimate PAR%.
The cumulative cases and controls were 4778 and 6271, respectively, based on 10 case-control studies conducted in India. Among the cases, 49.1% were bidi smokers and 7.7% cigarette smokers, while they were 19.9% and 10.3%, respectively, among controls. Pooled odds ratio (OR) of bidi smoking for oral cancer was 3.3 [95% confidence interval (CI), 3.0-3.6] and 2.6 (95% CI 1.8-3.8), respectively, based on fixed- and random-effects model. Cigarette smoking, on the other hand, did not show any significant association. PAR% of bidi smoking for oral cancer ranged from 4.7% to 51.6% on individual study basis, while they were 31.4% and 24.1%, respectively, based on OR derived from fixed- and random-effects models. PAR% was 5.8% and 8.7% based on single study estimate from Pakistan and Sri Lanka, respectively.
Bidi smoking is considered to account for a sizeable number of oral cancers in south Asian countries, which implies that cessation programs should be formulated and implemented vigorously.

13 Reads
  • Source
    • "Although treatment of lung cancer has improved, mortality remains high in lung cancer patients. A growing body of research suggests that naturally occurring compounds can act as antioxidants as well as cancer preventative and therapeutic agents (Parkin et al., 1999; Rahman et al., 2005; Hashibe et al., 2007). Development of chemotherapeutic agents with maximal anti-tumor activity and minimal toxicity has become a favorable route for cancer management. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mushrooms are known to complement chemotherapy and radiation therapy by countering the side effects of cancer. Recently, there has been great interest in isolation of novel bioactive compounds from mushrooms due to their numerous health beneficial effects. Chemically water-extractable polysaccharide (MFKF-AP1β), with a molecular weight of 12 kDa, was isolated from fruiting bodies of mushroom Fomes fomentarius. In this research, we investigated the anti-tumor effects of MFKF-AP1β on human lung carcinoma A549 cells. Results showed that MFKF-AP1β markedly inhibited A549 cell growth in a dose-dependent manner based on the amount of lactate dehydrogenase (LDH) released and morphological alterations. In addition, MFKF-AP1β induced cellular apoptosis by causing single-stranded DNA breakage, as evidenced by apoptosis assay. Furthermore, MFKF-AP1β (25–100 μg/ml) significantly induced single-stranded DNA breakage in A549 cells, as shown by comet assay. Taken together, our results demonstrate that MFKF-AP1β has strong anti-tumor effects mediated through induction of apoptosis. Therefore, MFKF-AP1β could be useful in lung chemotherapy.
    Saudi Journal of Biological Sciences 11/2014; 11(4). DOI:10.1016/j.sjbs.2014.11.022 · 1.26 Impact Factor
  • Source
    • "Squamous cell carcinoma of the oral cavity is the sixth most frequent cancer in the United States [1]. In recent years, the survival rate for oral cancer has dropped dramatically in United States [4] [5], Hungary [6], India [7] [8], south Asia [9], and Taiwan [10] [11]. Surgery, radiotherapy, and chemotherapy are vital complementary strategies for the treatment of head and neck cancer [12]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Oral cancer, the largest subset of head and neck cancer, has become one of the most lethal malignancies during the last two decades. Although several diagnostic tools have been applied for the early detection of oral malignancies, it is still urgent to identify novel tumor markers. In this study, we explored the cell surface N-glycomes of primary cultured human oral keratinocytes (HOK), immortalized human gingival keratinocytes (SG cells), and oral squamous cell carcinoma (OC2). Methods: Enzymatically hydrolyzed cell surface N-glycans were analyzed by MALDI-TOF mass spectrometry. Results: High levels of fucosylated N-glycans, especially core-fucosylated N-glycans, were observed on the OC2 cell surface whereas the major N-glycans on SG and HOK cells were high mannose type. In addition, the mRNA expression level of fucosyltransferase 8 was elevated significantly in OC2 cells than in SG and HOK cells. Core-fucosylated glycoproteins of OC2 cells were then purified with lectin affinity chromatography and a key adhesion molecule in cancer cells, CD147, was identified. Finally, overexpression of cell surface CD147 was confirmed on OC2 cells and oral cancer tissues (tissue array). Conclusions: CD147 was discovered by glycoproteomic approaches and suggested to be a potential novel tumor marker for oral cancer diagnosis.
    Clinica chimica acta; international journal of clinical chemistry 10/2012; 420. DOI:10.1016/j.cca.2012.10.019 · 2.82 Impact Factor
  • Source

Show more